StonvexLoading…
StonvexStonvexStonvexCore line items from CRBU's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $11.16M | $9.99M | $34.48M | $13.85M |
Operating Income | $-148.34M | $-166.62M | $-116.06M | $-106.40M |
Net Income | $-148.13M | $-149.10M | $-102.07M | $-99.42M |
EPS (Diluted) | $-1.59 | $-1.65 | $-1.38 | $-1.64 |
Total Assets | $175.37M | $313.31M | $432.21M | $373.76M |
Total Liabilities | $53.19M | $60.36M | $63.81M | $72.89M |
Cash & Equivalents | $12.36M | $16.29M | $51.16M | $58.34M |
Free Cash Flow OCF − CapEx | $-112.35M | $-143.08M | $-104.90M | $-97.42M |
Shares Outstanding | 95.14M | 92.38M | 88.45M | 61.03M |